Advanced Materials · 2020 · 301 citations · 30 references
PharmacyImmunologyOncologyDrug DeliveryImmunotherapyTumor MicroenvironmentCancer ImmunotherapyCombination ImmunotherapyImmunotherapy For Solid TumorsNanomaterials For Drug DeliveryNanoparticle DesignTumor Microenvironment ModulationBiomaterial-based ImmunomodulationImmune Modulation By Extracellular VesiclesImmunosuppressive MicroenvironmentOuter Membrane StructureTumor Microenvironment ResponsivenessTumor-associated Macrophage Reprogramming
The highly immunosuppressive tumor microenvironment in solid tumors often dampens the efficacy of immunotherapy. The study seeks to coat bacterial outer membrane vesicles with calcium phosphate shells to overcome antibody‑dependent clearance and high toxicity from intravenous injection, enabling potent and safe tumor microenvironment reprogramming. Calcium phosphate shells shield OMVs, enable pH‑sensitive release, and can be conjugated with folic acid or photosensitizers to support combination therapies with synergistic effects. Coated OMVs act as powerful immunostimulants, neutralize acidic TME, and induce M2‑to‑M1 macrophage polarization, resulting in enhanced antitumor activity.
Abstract The highly immunosuppressive tumor microenvironment (TME) in solid tumors often dampens the efficacy of immunotherapy. In this study, bacterial outer membrane vesicles (OMVs) are demonstrated as powerful immunostimulants for TME reprogramming. To overcome the obstacles of antibody‐dependent clearance and high toxicity induced by OMVs upon intravenous injection (a classic clinically relevant delivery mode), calcium phosphate (CaP) shells are employed to cover the surface of OMVs, which enables potent OMV‐based TME reprograming without side effects. Meanwhile, the pH‐sensitive CaP shells facilitate the neutralization of acidic TME, leading to highly beneficial M2‐to‐M1 polarization of macrophages for improved antitumor effect. Moreover, the outer shells can be integrated with functional components like folic acid or photosensitizer agents, which facilitates the use of the OMV‐based platform in combination therapies for a synergic therapeutic effect.
30
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi, Steven O’Day, David F. McDermott et al. · New England Journal of Medicine · 2010 · 15.2K citations · Full text
Jennifer Couzin-Frankel · Science · 2013 · 2K citations
Medicine, Immunology, Oncology +13
Molecular tectonics in biomineralization and biomimetic materials chemistry
Stephen Mann · Nature · 1993 · 1.2K citations